Insider: Zalevsky Jonathan Chief R&D Officer - NEKTAR THERAPEUTICS
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 17,462 | 0 | 17,462 |
| Value | $971,236.44 | $0.00 | $971,236.44 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/04/2025 | DDS | 307 | Direct | COM | $35.69 | $10,956.83 | 17,462 |
| 09/04/2025 | DDS | 432 | Direct | COM | $33.60 | $14,515.20 | 17,958 |
| 09/04/2025 | DDS | 793 | Direct | COM | $32.43 | $25,716.99 | 18,390 |
| 09/04/2025 | DDS | 189 | Direct | COM | $34.41 | $6,503.49 | 17,769 |
| 09/02/2025 | DDS | 485 | Direct | COM | $30.10 | $14,598.50 | 19,183 |
| 08/19/2025 | DDS | 725 | Direct | COM | $26.59 | $19,277.75 | 19,668 |
| 05/19/2025 | DDS | 10,712 | Direct | COM | $0.67 | $7,177.04 | 305,892 |
| 02/19/2025 | DDS | 10,300 | Direct | COM | $1.01 | $10,403.00 | 316,604 |
| 12/19/2024 | DDS | 51,115 | Direct | COM | $0.94 | $48,048.10 | 326,904 |
| 11/19/2024 | DDS | 7,785 | Direct | COM | $1.01 | $7,862.85 | 243,019 |
| 08/19/2024 | DDS | 6,866 | Direct | COM | $1.28 | $8,788.48 | 250,804 |
| 05/17/2024 | DDS | 7,355 | Direct | COM | $1.75 | $12,871.25 | 257,670 |
| 02/20/2024 | DDS | 9,014 | Direct | COM | $0.68 | $6,129.52 | 265,025 |
| 11/17/2023 | DDS | 9,646 | Direct | COM | $0.49 | $4,726.54 | 274,039 |
| 08/16/2023 | DDS | 9,703 | Direct | COM | $0.78 | $7,568.34 | 283,685 |
| 05/16/2023 | DDS | 9,791 | Direct | COM | $0.72 | $7,049.52 | 293,388 |
| 02/16/2023 | DDS | 10,484 | Direct | COM | $3.00 | $31,452.00 | 303,179 |
| 11/16/2022 | DDS | 13,460 | Direct | COM | $3.57 | $48,052.20 | 313,663 |
| 08/18/2022 | DDS | 73,716 | Direct | COM | $4.65 | $342,779.40 | 327,123 |
| 08/16/2022 | DDS | 10,560 | Direct | COM | $4.76 | $50,265.60 | 400,839 |
| 05/16/2022 | DDS | 21,673 | Direct | COM | $3.95 | $85,608.35 | 276,399 |
| 02/16/2022 | DDS | 10,912 | Direct | COM | $10.95 | $119,486.40 | 274,122 |
| 11/16/2021 | DDS | 20,869 | Direct | COM | $13.16 | $274,636.04 | 232,084 |
| 08/16/2021 | DDS | 7,662 | Direct | COM | $13.83 | $105,965.46 | 212,803 |
| 05/17/2021 | DDS | 31,111 | Direct | COM | $18.30 | $569,331.30 | 235,065 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research